指南与共识心血管技术与安全

COVID-19 期间心血管疾病的预防与管理:欧洲预防心脏病学协会、欧洲心血管影像协会、心血管护理与相关专业协会、欧洲经皮心血管介入协会及欧洲心脏病学会心力衰竭协会的临床共识声明

Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, the Association of Cardiovascular Nursing & Allied Professions, the European Association of Percutaneous Cardiovascular Interventions, and the Heart Failure Association of the ESC.
指南 / 共识 · Eur J Prev Cardiol · 2025-09-18

该临床共识声明由欧洲心脏病学会多个协会共同制定,旨在全面概述 COVID-19 各阶段的心血管预防策略,包括急性感染、既往感染、Long COVID、再感染和疫苗接种后事件相关的心血管风险。关键推荐聚焦于预防和管理急性或既往 COVID-19 患者的心血管表现、实施针对性心血管康复以及引入干预措施以减轻 Long COVID 的严重程度。声明还强调生活方式调整和个体化治疗以改善患者结局,并指出需持续研究以填补现有知识空白、优化预防策略。

要点

  • COVID-19 可在急性期和急性期后触发并加重心血管并发症。
  • 部分个体出现长期后遗症,统称为 Long COVID。
  • 再感染和 COVID-19 疫苗不良反应可能促成心血管事件。

核心结论

  • COVID-19 与心血管病存在复杂相互作用,需在急性感染、既往感染、Long COVID、再感染和疫苗接种后事件等各阶段实施心血管预防策略,并开展针对性康复和个体化治疗。

研究设计与样本

  • 欧洲心脏病学会多个协会共同制定的临床共识声明。

临床应用与阅片要点

  • 关注急性或既往 COVID-19 患者的心血管表现,进行预防和管理。
  • 实施针对性的心血管康复。
  • 引入干预措施以减轻 Long COVID 的严重程度。
  • 强调生活方式调整和个体化治疗以改善患者结局。

局限性

  • COVID-19 及其长期心血管影响仍在演变,需持续研究以解决现有知识空白。
  • 未来研究应优先考虑不同人群预防措施的个体化、完善康复策略并推进长期心血管照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The coronavirus-associated disease 2019 (COVID-19) pandemic has posed significant challenges due to the complex interplay between SARS-CoV-2 infection and cardiovascular disease. COVID-19 can trigger and exacerbate cardiovascular complications, observed both during the acute phase of infection and in the post-acute phase, with some individuals developing long-term sequelae collectively termed Long COVID. Additionally, reinfection and adverse reactions to COVID-19 vaccines may contribute to cardiovascular events. This clinical consensus statement, developed by associations of the European Society of Cardiology, aims to provide a comprehensive overview of cardiovascular prevention strategies across all stages of COVID-19. These include addressing cardiovascular risk associated with acute infection, prior infection, Long COVID, reinfection, and post-vaccination events. Key recommendations focus on preventing and managing cardiovascular manifestations in patients with acute or prior COVID-19, implementing targeted cardiovascular rehabilitation, and introducing interventions to mitigate the severity of Long COVID. The document also emphasizes lifestyle modifications and personalized therapeutic approaches to enhance patient outcomes. Given the evolving nature of COVID-19 and its long-term cardiovascular implications, ongoing research is crucial to address existing knowledge gaps, optimize preventive strategies, and improve patient care. Future studies should prioritize the individualization of preventive measures for diverse populations, refine rehabilitation strategies, and advance long-term cardiovascular care, ensuring that evidence-based practices continue to evolve alongside emerging data.

来源:Eur J Prev Cardiol,查看原文。版权归原作者所有。

引用

  1. Vassiliou VS, Tsampasian V, Luchian ML, et al. Cardiovascular disease prevention and management in COVID-19: a clinical consensus statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging, the Association of Cardiovascular Nursing & Allied Professions, the European Association of Percutaneous Cardiovascular Interventions, and the Heart Failure Association of the ESC. Eur J Prev Cardiol. 2025. PMID: 40973114. doi:10.1093/eurjpc/zwaf540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。